Sigma Pharma Says Finance Chief Smith Quits, KPMG's Watson to Act in Role

Sigma Pharmaceuticals Ltd. Chief Financial Officer Mark Smith has resigned. The company named Mark Watson to act in the role until a replacement is named.

To contact the reporter on this story: Tim Smith in Sydney at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.